June 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
According to market estimations, the clavulanic acid series API market, valued at US$ 385 million in 2023, is projected to reach US$ 777.66 million by 2034, driven by rising antibiotic resistance and R&D. North America leads, Asia-Pacific grows fastest, with potassium clavulanate and oral meds dominating....
April 21, 2026
According to research analysis, the global Factor Xa inhibitors market, valued at US$ 22.1 billion in 2023, is projected to reach US$ 41.52 billion by 2034, driven by rising cardiovascular diseases. North America leads, while Asia-Pacific shows fastest growth. Key players include Pfizer, Bayer, and AstraZeneca....
April 21, 2026
According to market projections, the blood product sector is expected to grow from USD 39.96 billion in 2025 to USD 62.65 billion by 2035, reflecting a CAGR of 4.6%, driven by rising demand in surgeries, cancer care, and trauma cases. North America leads in revenue, while Asia-Pacific shows the fastest growth. RBCs and blood stations dominate the m...
April 21, 2026
According to market estimations, the global thrombopoietin receptor agonists industry, valued at US$ 1.85 billion in 2023, is set to reach US$ 3.74 billion by 2034, driven by rising platelet-related disorders like ITP and AML. Key trends include FDA approvals, growing R&D, and increasing use in hospitals. North America leads, while Asia-Pacif...
April 21, 2026
North America dominated the human blood products market, fueled by regular donation drives, widespread facilities and government efforts to improve blood storage and awareness. In the U.S., 6.8 million people donate annually, while 52% of Canadians have needed blood or blood products....
April 21, 2026
According to market forecast, the global oral thrombopoietin receptor agonists market is projected to reach US$ 9.95 billion by 2034, driven by rising cases of thrombocytopenia and advancements in TPO-RAs. North America leads, while Asia-Pacific shows strong growth potential. Key players include Novartis, Sobi, and Shionogi....
April 21, 2026
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023, the U.S. FDA authorized Teva's Alvaiz (eltrombopag) tablets for treating thrombocytopenia in adults...
April 21, 2026
Polymerase chain reaction (PCR) is a DNA amplification method widely used in diagnostics and biotechnology. In 2022, India conducted 600-700 million diagnostic tests, adding 1,390 biotech startups. PCR enzymes drive efficiency and sustainability. The U.S. and UK continue to invest heavily in biotech innovation....
April 21, 2026
The global human coagulation factor VII market is projected to grow from USD 1.21 billion in 2023 to USD 1.82 billion by 2034, driven by rising surgeries, trauma cases, and hemophilia prevalence. North America leads, while Asia Pacific is the fastest-growing region....
April 21, 2026
The Hepatitis A vaccine market, valued at US$ 759.01 million in 2024, is projected to reach US$ 948.16 million by 2034. Growth is driven by rising outbreaks, immunization awareness, and travel. Asia-Pacific leads, with North America growing fastest; key players include GSK, Merck, and Sanofi....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
